STEMCELL INSTITUTE INC.

Altre lingue StemCell Institute Inc.

Azioni

7096

JP3399640006

Mercato chiuso - Japan Exchange Altri mercati azionari 08:00:00 28/06/2024			Variaz. 5gg	Var. 1 gen.
1.689 ^JPY	+0,96%		+3,81%	-21,22%

2023	Cuorips Inc. ha completato un'IPO per un importo di 3,432 miliardi di yen.	CI
2023	Cuorips Inc. ha presentato un'IPO.	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Certain Common Shares of Cuorips Inc. are subject to a Lock-Up Agreement Ending on 23-DEC-2023.	23/12
Certain Common Shares of Cuorips Inc. are subject to a Lock-Up Agreement Ending on 24-SEP-2023.	24/09/23
Cuorips Inc. has completed an IPO in the amount of Â¥3.432 billion.	27/06/23
Cuorips Inc. has filed an IPO.	23/05/23
Certain Common Stock of StemCell Institute Inc. are subject to a Lock-Up Agreement Ending on 21-DEC-2021.	21/12/21
Certain Common Stock of StemCell Institute Inc. are subject to a Lock-Up Agreement Ending on 22-SEP-2021.	22/09/21
StemCell Institute Inc. has completed an IPO in the amount of ¥2.32624 billion.	25/06/21
StemCell Institute Inc. has filed an IPO.	21/05/21
CUORiPS Inc. announced that it expects to receive ¥2 billion in funding from Asahi Intecc Co., Ltd., StemCell Institute Inc., Dai-Dan Co., Ltd., Taiko Pharmaceutical Co.,Ltd., Kyoto University Innovation Capital Co., Ltd., Terumo Corporation and other investors	04/12/20
StemCell Institute Inc. has withdrawn its IPO.	23/03/20
StemCell Institute Inc. has filed an IPO.	05/03/20
TrimGen Holdings Co., Ltd completed the acquisition of 56.57% stake in StemCell Institute Inc. from Nihon Trim Co., Ltd..	31/03/15
TrimGen Holdings Co., Ltd agreed to acquire 56.57% stake in StemCell Institute Inc. from for Nihon Trim Co., Ltd. approximately ¥940 million.	19/03/15
Nihon Trim Co., Ltd. completed the acquisition of 50.1% stake in Stemcell Institute from Kunimatsu Yamamoto and funds sponsored by Japan Asia Investment Co. Ltd., JAFCO Co., Ltd. and Ant Capital Partners Co., Ltd.	25/09/13
Nihon Trim Co., Ltd. agreed to acquire a 50.1% stake in Stemcell Institute from Kunimatsu Yamamoto and funds sponsored by Japan Asia Investment Co. Ltd., JAFCO Co., Ltd. and Ant Capital Partners Co., Ltd. for approximately ¥790 million.	09/09/13

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

I nostri contenuti gratuiti ti aiutano a mettere al sicuro e ad aumentare la performance dei tuoi investimenti

Assicurare i miei Investimenti

fermer